Follow LF0 researchXLinkedInSubstackFacebook
tput: No value for $TERM and no -T specified

Research

Zoetis (ZTS) Stock Analysis & Research

Latest rating
Hold
Latest report
Sep 15, 2026
Reports
1
Sector
Healthcare

Zoetis (ZTS) develops, manufactures, and commercializes medicines, vaccines, diagnostics, and precision animal health services for companion animals and livestock. Companion animal products generated $6.6B of 2025 revenue and livestock $2.8B, across more than 100 countries.

Backtesting dashboard with equity curve and drawdown analysis
Quantitative market report dashboard with factor and risk analysis
SEC filing comparison with highlighted document changes